Related by context. All words. (Click for frequent words.) 71 Hematide ™ 68 Begins Dosing 68 Initiates Enrollment 68 molecular imaging radiopharmaceutical 68 midstage clinical 67 OMAPRO ™ 67 Completes Patient Enrollment 67 LymphoStat B TM 67 HepeX B 67 CRMD# 67 Zemiva TM 67 Nasdaq PGNX today 67 overactive bladder AA# 67 BLA filing 67 Acetavance TM intravenous acetaminophen 66 pharmacogenomic translational research 66 KRYSTEXXA TM pegloticase 66 please visit http:/www.vandapharma.com 66 Maxy G# 66 Silenor ® doxepin 66 IG HCR ;) CO 66 please visit www.dyax.com 66 highly purified pasteurized 66 Inc. www.micromet inc.com 66 Submits Biologics License Application 66 Kosan dependence 66 Empatic ™ 66 candidate Hematide TM 66 faropenem medoxomil 66 SinuNase ™ 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 recombinant PSMA vaccine 65 Therapeutic Competitors Companies 65 HEPLISAV ™ 65 PDX pralatrexate 65 include Phenoptin TM 65 ALTROPANE R 65 Crofelemer budesonide foam 65 Naglazyme R 65 albiglutide 65 JOULFERON 65 Initiates Phase III 65 novel oral anticoagulant 65 HuMax TAC 65 proprietary intravenous formulation 65 Xcytrin R 65 proprietary intranasal insulin 65 Biologic License Application BLA 65 tramiprosate ALZHEMED TM 65 sterile lidocaine patch 65 Zenvia ™ 65 Submits Response 65 Ereska 65 successfully commercialize Iluvien 65 Valtropin 65 including eniluracil ADH 65 Q#IR 65 candidate SILENOR TM 65 Nasdaq NPSP announced 65 please visit http:/www.atherogenics.com 65 SILENOR 65 PF # [002] 65 Initiates Phase II 65 Evoltra ® 64 Initiates Clinical Trial 64 acetonide FA 64 FOLOTYN ® 64 Vascular Wrap TM 64 Inc. Nasdaq VVUS 64 Presents Positive 64 using VIAdel TM 64 TRANSDUR Bupivacaine 64 candidate deforolimus 64 Excellarate TM 64 TRACON Pharmaceuticals 64 JZP 64 oral salmon calcitonin 64 visit www.genenews.com 64 gepirone ER 64 Nasdaq CYCC Nasdaq CYCCP 64 commercialize CorMedix drug 64 MAA submission 64 delivery polymer matrix 64 XP# XP# 64 Nasdaq ENCY 64 novel therapeutic antibodies 64 BRILINTA 64 investigational hepatitis B 64 apricitabine ATC 64 Archexin 64 Nasdaq VRTX 64 SUTENT ® 64 transmucosal delivery system 64 Entereg R 64 Files IND 64 candidate XP# 64 NASDAQ SCRX specialty 64 Spiegelmer ® 64 Nasdaq SGEN 64 Telik logo TELINTRA 64 lintuzumab SGN 64 Linjeta TM 64 markets HP Acthar 64 outlicensed 64 Pegloticase 64 Somatuline Depot 64 orally inhaled migraine 64 HEPLISAV TM 64 please visit www.medicinova.com 64 naronapride 64 selective estrogen receptor modulator 64 NASDAQ PGNX 64 Acetavance TM 64 Nasdaq HALO 63 candidate REP# 63 TELINTRA R 63 intranasal insulin product 63 Oracea TM 63 XL# anticancer compounds 63 intranasal formulation 63 IV APAP 63 Unit Dose Budesonide 63 CIP TRAMADOL ER 63 Nasdaq DVAX 63 indiplon capsules 63 Testosterone MDTS ® 63 OvaRex R 63 Nasdaq CLDX 63 vigabatrin GABA aminotransferase inhibitor 63 delivers fluocinolone acetonide FA 63 candidates Azedra TM 63 Amigal TM 63 Inc. Nasdaq SEPR 63 Submits NDA 63 PANVAC VF 63 mesylate tablets approved 63 Entereg TM 63 sitaxsentan sodium 63 subsidiaries visit http:/www.apricusbio.com 63 DPX Survivac 63 Files Investigational 63 Nasdaq NBIX 63 MAXY alpha 63 GVAX R 63 CB2 selective receptor agonist 63 Trofex ™ 63 virus HCV protease inhibitor 63 zolpidem tartrate sublingual tablet 63 Rhucin ® recombinant 63 SinuNase TM 63 intravenous acetaminophen 63 vosaroxin 63 NV1FGF 63 Inc. Nasdaq AFFY 63 Fx #A 63 anti botulism antibody 63 Inc. Nasdaq IMGN 63 R MSCRAMM 63 TOCOSOL Camptothecin 63 R sorafenib tablets 63 selective A2A adenosine receptor 63 Azedra TM 63 methylnaltrexone bromide 63 candidate AQ4N 63 adecatumumab MT# 63 Iluvien ® 63 Personalized Immunotherapy 63 ELADUR ™ 63 NYSE Amex PTN 63 PDE4 inhibitor 63 Alzheimer disease cognitive dysfunction 63 Risperidone Oral Solution 63 Surfaxin LS 63 adenosine injection 63 Nasdaq IDRA 63 hypoxia activated prodrug 63 Receives Approvable Letter 63 zileuton CR 63 Panzem R 63 Phase Ib IIa 63 Nasdaq RGEN 63 oxymorphone ER 63 Nasdaq NPSP 63 alvespimycin 63 BEMA Granisetron 63 Oxytrex TM 62 Nasdaq ONXX 62 VIVITROL ® 62 oral methylnaltrexone 62 EGS# 62 SYCREST 62 severe gastroparesis 62 JAK inhibitor 62 includes TOLAMBA TM 62 oncolytic virus therapies 62 Soliris TM eculizumab 62 metaglidasen 62 AERx iDMS 62 GTC NASDAQ GTCB 62 initiated Phase Ib 62 Veronate R 62 deforolimus 62 glucokinase activator 62 Prodarsan ® 62 Dynepo TM 62 NasdaqGM SPPI 62 Ambrisentan 62 ENABLE Phase 2 62 candidate Zemiva TM 62 Inc Therapeutic Competitors 62 Oral NKTR 62 AVANIR Pharmaceuticals Inc. 62 Silodosin 62 PROVENGE ® 62 Initiates Clinical 62 M# rationally 62 PAION AG ISIN 62 Nasdaq DYAX 62 AAG geldanamycin analog 62 Frova ® 62 MOVIPREP R 62 Dyax logo 62 Nasdaq IDIX 62 P#X# antagonist 62 Asentar TM 62 Zybrestat 62 Glybera R 62 Receives Fast Track 62 CRD5 62 Submits Supplemental 62 Inc FRX FRX 62 bardoxolone 62 cosmetic cosmeceutical products 62 Inc. Nasdaq MITI 62 Synavive ™ 62 StaphVAX R 62 COLAZAL R 62 RIGScan CR 62 2A receptor agonist 62 Inc. NASDAQ AVNR 62 Inc. NASDAQ NOVC 62 sNDAs 62 biomarkers predictive 62 PLK1 SNALP 62 Aradigm Logo 62 recombinant biopharmaceutical 62 Achieves Primary Endpoint 62 signal detection CTSD 62 dimebon latrepirdine 62 Prodarsan R 62 Corlux 62 KRYSTEXXA TM 62 Presents Positive Preclinical 62 CONBRIZA 62 Begins Clinical Trial 62 SUCCEED trial 62 Genz # 62 MAXY VII 62 Albugon 62 rxRNA 62 Hematide TM 62 clinical trials dacetuzumab SGN 62 Prestara 62 visit http:/www.mannkindcorp.com 62 Inc. Nasdaq NEOL 62 MyVax personalized immunotherapy 62 Allovectin 7 62 motexafin gadolinium Injection 62 BioSante Pharmaceuticals Announces 62 Please visit www.antisoma.com 62 Ostabolin C TM 62 NASDAQ IMCL 62 ocular formulation 62 E2F Decoy 62 sapacitabine CYC# 62 dexanabinol 62 Receives Orphan Drug Designation 62 staphylococcal vaccine 62 aerosolized AAT 62 PRNewswire FirstCall Genta Incorporated 62 Nasdaq GNTA 62 Exelixis compounds 62 Troxatyl 62 Inc. OTCBB VODG 62 romazarit 62 basal insulin analogue 62 Reports Preclinical Data 62 PNP inhibitor 61 topical antifungal product 61 doxepin HCl 61 HCV antiviral 61 investigational humanized monoclonal antibody 61 Anturol ® 61 SAR# [002] 61 ILUVIEN ® 61 Nasdaq IDRA today 61 compound ISA# 61 Budesonide foam crofelemer 61 alvimopan Investigational 61 Pruvel TM 61 ACAPODENE TM 61 IV acetaminophen 61 NeoLipid drug 61 Announces Tentative Approval 61 NASDAQ DYAX 61 BRIM3 61 Reveals Positive 61 Phase 2a clinical trials 61 Lupuzor 61 Civacir 61 infectious diseases autoimmune 61 FACTIVE R gemifloxacin 61 forodesine 61 Prednisporin TM 61 TRIOLEX HE# APOPTONE HE# 61 rasagiline tablets 61 Empatic TM 61 Therapeutic Competitors 61 Zensana 61 NasdaqGM NTEC today 61 RANK Ligand inhibitor 61 Somatuline Autogel 61 oral prodrug 61 MAb therapy 61 visit www.noven.com 61 Inc. OTCBB ALRX 61 SPL# Gel vaginal microbicide 61 alvimopan 61 IND submission 61 NYSE AMEX PLX 61 Aganocide 61 MAGE A3 ASCI 61 oral ridaforolimus 61 mertansine 61 MSCRAMM ® 61 SURFAXIN 61 Nasulin ™ 61 STEDESA 61 Drew Fromkin President 61 candidate TNFerade biologic 61 dextromethorphan quinidine 61 Behcet uveitis 61 Aurexis 61 lomitapide 61 Canvaxin 61 postoperative ileus POI 61 GSK# [002] 61 PHX# 61 Corp. ADLR 61 Inc NGSX 61 Allovectin 7 r 61 LidoPAIN SP 61 Rotarix ® 61 PrevOnco 61 histamine dihydrochloride 61 Idera Pharmaceuticals 61 acyclovir Lauriad R 61 gets USFDA nod 61 CoTherix logo 61 submitted Marketing Authorization 61 BEMA TM Fentanyl 61 Cinryze ™ 61 Receives Orphan Drug 61 Tramiprosate ALZHEMED TM 61 Nasdaq PCYC 61 investigational hepatitis C 61 visit www.targanta.com 61 Cloretazine ® 61 NU# direct 61 Insmed Incorporated NASDAQ INSM 61 tiapamil 61 Inc XNPT 61 Ketotransdel 61 GLPG# 61 THR beta agonist 61 molecular chaperone regulation 61 FM VP4 61 LEVADEX TM 61 pharmacokinetic PK study 61 please visit http:/www.sunesis.com 61 CRTX 61 pralatrexate injection folate analogue 61 OTCBB UGNE http:/www.unigene.com 61 Presents Preclinical 61 visit www.sciclone.com 61 Solazed TM 61 Febuxostat 61 Preos 61 PrevOnco ™ 61 novel MetAP 2 61 BENLYSTA ® 61 ONCONASE R 61 Inc. Nasdaq BIOD 61 Vertex hepatitis C 61 Oral Calcitonin 61 Nasdaq SPPI 61 ALN PCS 61 Angiocept 61 Generx ™ 61 Safinamide 61 candidate CRLX# 61 Nasdaq IMGN 61 developing ACAPODENE 61 elotuzumab 61 MediGene focuses 61 mocetinostat MGCD# 61 non nucleoside HCV 61 pulls Darvon painkiller 61 pioglitazone hydrochloride 61 HepeX B TM 61 Nasdaq AMLN 61 IMiDs R 61 candidate MyVax 61 CEFF financings subject 61 ASX PGL 61 Sulonex TM 61 Bicifadine 61 phase IIb clinical 61 Through Glycoscience R 61 nasal calcitonin product 61 NASDAQ CXSP announced 61 alemtuzumab MS 61 TRANSDUR ® 61 Genentech sanofi aventis 61 NASDAQ SOMX specialty 61 By JAMAAL ABDUL 61 hyaluronidase enzyme 61 Urocidin 61 Sanctura XR 61 technology visit http:/www.genmab.com 61 Earns Milestone Payment 61 dutogliptin 61 Phenoptin 61 Novolimus 61 product candidate Lpathomab 61 Trofex 61 Nabi HB Intravenous 61 Nasdaq AEGR 61 5 lipoxygenase inhibitor 61 sNDA submission 61 compound KOS 61 Inc. NASDAQ IDIX 61 EVIZON TM 61 bicifadine 61 BiovaxID TM 61 TBC# 61 Dyloject TM 61 Zemiva ™ 61 novel trazodone formulation 61 Ventrus 61 Selzentry Celsentri 61 Inc. Nasdaq VRUS 61 targeted radiotherapeutic 61 Inc. Nasdaq ELGX 61 Partnering Agreements 61 exploratory Phase IIa 61 Inc. NASDAQ SGEN 61 Desvenlafaxine 61 telomerase inhibitor drug 60 ENTEREG ® 60 LymphoStat B belimumab 60 torsemide ER 60 hoFH 60 NSABP C 60 PORxin TM platforms 60 Phase IIb clinical trials 60 LEVADEX ™ 60 Phase III ADT 60 VIAject R 60 IMA# 60 CDP# 60 Seroquel quetiapine fumarate 60 Inc. Nasdaq MAXY 60 Nasdaq OPTR 60 PRIMO CABG2 60 NASDAQ ALTH 60 Act PDUFA date 60 investigational oral hepatitis C 60 Qutenza TM 60 Corporation GENZ GENZ 60 OvaRex ® MAb 60 generic Copaxone 60 Aganocide ® 60 Phase 1a clinical 60 phase IIb trial 60 dirucotide MBP# 60 ARIKACE ™ 60 CEL SCI Phase III 60 INS# [001] 60 treats acute lymphoblastic 60 Amoxicillin PULSYS Phase III 60 drug figitumumab 60 PI3K/Akt pathway inhibitor 60 Rhucin R 60 ruxolitinib 60 GEM OS2 60 SPARLON 60 Nasdaq ALTH 60 cannabinor 60 CA9 SCAN 60 vitro dissolution 60 fusion enhancers 60 rThrombin 60 Augment TM 60 Trubion Pharmaceuticals TRBN 60 memantine HCl 60 Ceflatonin R 60 TNFerade ™ 60 ® fenofibrate capsules 60 fidaxomicin Phase 60 OMNARIS HFA 60 Inc. NASDAQ EVVV 60 NUEDEXTA ™ 60 Sufentanil 60 nalbuphine ER 60 GERD migraine headaches 60 leading oral taxane 60 XL# XL# XL# XL# 60 LUNESTA TM 60 Exherin TM 60 EVIZON TM squalamine lactate 60 Omigard 60 Meritage Pharma 60 Salmedix 60 Feraheme ® 60 intravenous AAT 60 clinical trials lintuzumab SGN 60 Zelrix 60 Aryplase 60 Inc. Nasdaq ATHX 60 Nasdaq ENZN 60 GED aPC 60 BEMA TM LA 60 NASDAQ ONXX 60 Licenses Novel 60 trastuzumab DM1 T DM1 60 Orapred ODT 60 Wellstat 60 Nasdaq ONXX today 60 EMPOWER ™ 60 Kiacta 60 Bifeprunox 60 Solazed 60 LibiGel ® 60 midstage trials 60 AcryMed Incorporated 60 Omigard TM 60 NASDAQ NOVN today 60 tezampanel 60 alogliptin 60 PDE# inhibitors 60 Nasdaq IDIX biopharmaceutical 60 Cellegy Pharmaceuticals 60 Albuferon albinterferon alfa 2b 60 Inc. NASDAQ HEPH 60 Idun Pharmaceuticals 60 oxypurinol 60 Enhanze 60 seliciclib CYC# 60 NASDAQ OSIR 60 developing ostarine selective 60 ATPace TM 60 faropenem 60 NASDAQ INGN 60 ENZON 60 compound INCB# 60 Inc. NASDAQ BPAX 60 Inc. NASDAQ AGIX 60 AFREZZA TM 60 oral immunomodulatory 60 IMiDs ® 60 HCV polymerase 60 Aegerion Pharmaceuticals Inc. 60 Balaglitazone 60 sitaxsentan 60 Nicotine Conjugate Vaccine 60 Emezine 60 Troxatyl TM 60 Nanobody R 60 Panzem ® 60 generation purine nucleoside 60 NASDAQ BDSI 60 Oglemilast 60 vaginally administered lidocaine 60 registrational 60 POSIDUR TM 60 TOCOSOL 60 Chimigen TM 60 ospemifene 60 OTCBB ARGA specialty 60 Proellex TM 60 GATTEX TM 60 NASDAQ NOVN 60 assigned PDUFA 60 COLAL PRED 60 RNA interference RNAi therapeutics 60 number NCT# ClinicalTrials.gov 60 Anturol TM 60 Pafuramidine 60 Stedesa 60 novel L DOS# 60 Nasdaq OSCI 60 hypoxia selective 60 markets COLAZAL 60 Perforomist TM formoterol fumarate 60 treat chronic sinusitis 60 SCIB1 60 GLP1 agonist 60 Skin Cholesterol Test 60 Successfully Completes Phase 60 superparamagnetic iron oxide nanoparticles 60 Annamycin 60 human C1 inhibitor 60 Auxilium Pharma 60 Raptiva R 60 CCR5 mAb 60 Georges Gemayel 60 midstage studies 60 atacicept 60 Perflubutane Polymer Microspheres 60 Nasdaq CBST 60 Phase III TRIST 60 Ecallantide 60 PREOS 60 NASDAQ VPHM 60 rALLy clinical trial 60 ZALBIN 60 NASDAQ OMER 60 Veronate 60 NASDAQ SHPGY 60 OMNARIS Nasal Spray 60 novel anti infective 60 Nasdaq MNKD 60 Mesafem 60 Targanta Therapeutics Corporation 60 Prosaptide 60 Voraxaze 60 Phase #b/#a clinical 60 Liprotamase 60 Xoma Ltd 60 TransVax 60 MCSP respectively 60 Pfizer inhaled insulin 60 commercializing anti infective 60 website http:/www.celsion.com 60 XOPENEX HFA MDI 60 Xenoport Inc. 60 Ista Pharmaceuticals Inc 60 NASDAQ FLML 60 Tibotec BVBA 60 confirmatory Phase III 60 Syncria albiglutide 60 SWX BSLN 60 Nasdaq ACHN 60 XOMA 3AB 60 Elagolix 60 CIP ISOTRETINOIN 60 solid tumors ZYBRESTAT 60 Gentamicin Surgical Implant 60 Investigational Oral 60 TRANSDUR ™ 60 Posiphen TM 60 Selective Electrochemical Tumor Ablation 60 Exalgo TM 60 Nasdaq MAPP 60 Regeneron Pharma 60 Cintredekin Besudotox 60 Namenda Memantine HCl 60 Methylphenidate Transdermal System 60 ALPMF 59 Targretin capsules 59 NASDAQ CLDX 59 XIAFLEX ™ 59 Delta opioid receptor 59 DepoMed 59 coronary stent merged 59 Femring ® 59 candidate brentuximab vedotin 59 orally disintegrating 59 EMPOWER TM 59 blood thinner prasugrel 59 kidney urologic 59 Panzem R NCD 59 Surfaxin lucinactant 59 supplemental biologics 59 sumatriptan DosePro 59 pivotal bioequivalence 59 torezolid phosphate 59 induced mucositis 59 candidates Dyloject TM 59 Anidulafungin 59 Phase 2b clinical trials 59 MethyPatch 59 NEBIDO R 59 Neo Kidney Augment 59 Orathecin 59 Dr. Flemming Ornskov 59 GVAX ® 59 Vidaza R 59 phase IIa clinical 59 Simulect 59 Orphan Drug designations 59 Aganocide TM 59 Receives Complete Response 59 Inc. NASDAQ CRTX 59 submitted Biologics License 59 John F. Thero 59 Alzhemed TM 59 recurrent metastatic ovarian cancer 59 Trastuzumab DM1 59 non porcine pancreatic 59 TSX SHQ 59 Meets Primary Endpoint 59 OTC BB PVCT 59 R lenalidomide 59 Zeneus 59 ATL# [002] 59 Nasdaq TRBN 59 omacetaxine mepesuccinate 59 Vidaza azacitidine 59 mitogen activated ERK kinase 59 novel emulsion formulation 59 KIACTA ™ 59 Inc. NASDAQ NBIX 59 Gamunex C 59 please visit www.middlebrookpharma.com 59 Difimicin 59 Proquin XR 59 combines bupropion 59 Phase IIb III 59 Launches Generic Version 59 Serdaxin ® 59 ® bortezomib 59 IND Investigational New 59 TransVax TM 59 Nasdaq CADX 59 Copegus R 59 eliglustat tartrate 59 ONCONASE ranpirnase 59 KALBITOR ® 59 Vilazodone 59 NASDAQ ISIS 59 Firazyr 59 CEQ# 59 inhibitor PPI 59 budesonide MMX Phase III 59 refractory chronic lymphocytic 59 molecular imaging radiopharmaceuticals 59 Cardio Vascu Grow 59 Alfacell proprietary ribonuclease 59 Cetrorelix 59 pafuramidine maleate 59 R#/MEM 59 Progenta TM 59 CCR9 antagonist 59 NYSE Amex PBTH 59 GATTEX ® 59 ELADUR TM 59 OMS#HP 59 Immunotherapeutic 59 #/#/# Cytokinetics Incorporated 59 HGS ETR2 59 Preotact 59 OVATURE 59 Ferumoxytol 59 Adnectin 59 pseudobulbar affect PBA 59 vapreotide acetate 59 Germany FSE SCH 59 KRN# 59 EP #R 59 TELINTRA 59 Androxal TM 59 SPRYCEL ® 59 LUCASSIN 59 Receive Milestone Payment 59 Campath ® 59 platforms GVAX 59 Cimzia TM 59 QNEXA ® 59 diarrhea predominant irritable 59 AdhTAP 59 FOLFOX6 chemotherapy regimen 59 Luramist 59 IMPACS R 59 Genentech Wyeth Pharmaceuticals 59 Presents Preclinical Data 59 Efficacy Results 59 Vernalis plc 59 zanolimumab 59 dose intramuscular 59 immunosuppressant therapies 59 TM pralatrexate injection 59 rhThrombin 59 Pivotal Phase III 59 reslizumab 59 RELISTOR ® 59 Octreolin 59 eritoran 59 clevidipine 59 severe hypercholesterolemia 59 Nasdaq HALO biopharmaceutical 59 Shire BioChem Inc. 59 Inc. Nasdaq MLNM 59 CYT# potent vascular disrupting 59 Nasdaq EPCT 59 NASDAQ NPSP 59 oral Janus kinase 59 apoptosis inducer 59 oral picoplatin 59 ChemGenex Pharmaceuticals Limited 59 aurora kinase 59 Urocidin TM 59 Announces Poster Presentations 59 solanezumab 59 NP2 Enkephalin 59 oral taxane 59 PSN# [001] 59 Initiated Phase 59 rhIGF-I/rhIGFBP-3 59 NASDAQ TARG 59 delivers sumatriptan 59 MoxDuo IR 59 generation DACH Platinum 59 Manja Bouman CEO 59 investigational atypical antipsychotic 59 Generx TM 59 Anavex #-# 59 eprodisate Fibrillex TM 59 Receives Milestone Payment 59 candidate Generx TM 59 CYT# vascular disrupting 59 Cleviprex TM clevidipine 59 therapeutic monoclonal antibody 59 investigational monoclonal antibody 59 forodesine hydrochloride 59 Inc. NASDAQ ACUS 59 Icatibant 59 pregabalin Lyrica 59 Inc. Nasdaq INFI 59 Kuvan TM sapropterin 59 AzaSite Plus 59 aripiprazole Abilify 59 PRN FDA Approves 59 CORLUX CORT # 59 Inc. Nasdaq SUPG 59 LibiGel ® testosterone gel 59 Synvisc ONE 59 sodium glucose transporter 59 concerning CombinatoRx 59 PREOS R 59 OTCBB HXBM developer 59 Bioaccelerate compounds under 59 ulimorelin 59 Triapine R 59 REMOXY NDA 59 novel histone deacetylase 59 Combivir Kivexa 59 AMITIZA ® 59 Granted Orphan Drug 59 TLK# 59 ONSOLIS TM 59 POSIDUR TM ELADUR TM 59 NSE SUNPHARMA 59 MK #B 59 Louis Drapeau 59 DIFICID ™ 59 NDA Submission 59 gabapentin enacarbil 59 phase IIa 59 Onconase 59 Corporation GENZ 59 tezampanel NGX# 59 tramiprosate Alzhemed TM 59 corticotropin injection 59 tivozanib AV 59 Replagal TM 59 next generation URAT1 59 Fodosine 59 AzaSite ISV 59 balsalazide tablet 59 refractory gout 59 Hsp# Inhibitor 59 Partnering Guide 59 therefore therapeutically equivalent 59 Nasdaq MITI biopharmaceutical 59 Staphylococcus aureus Immune Globulin 59 docetaxel Taxotere R 59 Somatuline R Autogel R 59 THALOMID 59 Inc. NASDAQ CVTX 59 Omnitarg 59 OncoVex 59 APTIMA HPV assay 59 breast cancer pill Tykerb 59 Acurox r Tablets 59 rusalatide acetate 59 Canvaxin TM 59 KAI Pharmaceuticals 59 granted Ortec 59 Potelligent Technology 59 ThermoDox ® clinical 59 ASONEP 59 CD# CEA 59 Phase IIb trials 59 Evoltra TM 59 treat dysmenorrhea 59 enoxaparin sodium injection 59 nanofiltered plasma derived 59 ViaDerm hPTH #-# 59 miconazole Lauriad 59 humanized interleukin 6 59 S OMX GEN 59 LEP ETU 59 liver resection surgeries 59 uterine fibroid induced 59 TransVax tm 59 Nasdaq ISIS 58 BEMA Buprenorphine 58 Inc. Nasdaq IDIX 58 Sudhir Agrawal D.Phil 58 GILD GILD 58 Acorda Therapeutics Nasdaq ACOR 58 Memryte 58 Inc. Nasdaq SVNT 58 PharmaVitae Profile 58 phase IIb III 58 highly selective adenosine 58 Application BLA 58 Aegerion Pharmaceuticals 58 Dexilant 58 Nasdaq INHX 58 specialty injectables 58 NDA resubmission 58 SGXP 58 OTCBB PYTO 58 DPP4 inhibitor 58 RECOTHROM ® 58 Vascular Disrupting Agent 58 clinical trials SGN 58 Pivotal Phase 58 REMOXY ® 58 generation PNP inhibitor 58 Romiplostim 58 Cannabinor 58 Cadence Pharmaceuticals Inc 58 EmbraceAC 58 peginesatide 58 Receives Positive Opinion 58 Panflu TM Sinovac 58 HCV protease inhibitors 58 Indaflex TM 58 Aflibercept 58 ularitide 58 markets Testim ® 58 factor VIIa 58 Allovectin 7 R 58 unique alkylating agent 58 Inhalation Powder 58 pentadentate logo R 58 Phase Ib II 58 AzaSite Xtra 58 multicenter Phase III 58 commercialize ZYFLO CR 58 Amlodipine Besylate 58 Paliperidone Palmitate 58 Factor VIIa 58 Nasdaq CRDC 58 Nycomed GmbH 58 adalimumab Humira 58 BEMA TM Buprenorphine 58 rhFVIIa 58 deCODE AF TM 58 NYSE Amex AIS 58 L BLP# 58 Nasdaq OSIP 58 Phase IIa clinical trials 58 CORT # estimates 58 evaluating tivozanib 58 cMET inhibitor 58 Vivecon 58 NASDAQ GNTA 58 Nasdaq BIIB 58 IL# PE#QQR 58 personalized dendritic 58 Initiates Phase 2b 58 defensin mimetic antibiotic 58 Tarvacin Anti Cancer 58 RELOVAIR ™ 58 Eraxis 58 Premarket Approval Application 58 Travelers Diarrhea vaccine 58 Exenatide LAR 58 Rhucin ® 58 Vectibix panitumumab 58 cMET 58 Increlex TM 58 PRECISE Trial 58 intravenous iclaprim potent